MCT14 Polyclonal Antibody

    • Catalog No.:YT2684
    • Applications:WB;ELISA
    • Reactivity:Human;Mouse
      • Target:
      • MCT14
      • Gene Name:
      • SLC16A14
      • Protein Name:
      • Monocarboxylate transporter 14
      • Human Swiss Prot No:
      • Q7RTX9
      • Mouse Swiss Prot No:
      • Q8K1C7
      • Immunogen:
      • The antiserum was produced against synthesized peptide derived from human MOT14. AA range:131-180
      • Specificity:
      • MCT14 Polyclonal Antibody detects endogenous levels of MCT14 protein.
      • Formulation:
      • Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
      • Source:
      • Polyclonal, Rabbit,IgG
      • Dilution:
      • WB 1:500 - 1:2000. ELISA: 1:10000. Not yet tested in other applications.
      • Purification:
      • The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
      • Concentration:
      • 1 mg/ml
      • Storage Stability:
      • -15°C to -25°C/1 year(Do not lower than -25°C)
      • Other Name:
      • SLC16A14;MCT14;Monocarboxylate transporter 14;MCT 14;Solute carrier family 16 member 14
      • Observed Band(KD):
      • 48kD
      • Background:
      • function:Proton-linked monocarboxylate transporter. Catalyzes the rapid transport across the plasma membrane of many monocarboxylates.,similarity:Belongs to the major facilitator superfamily. Monocarboxylate porter (TC 2.A.1.13) family.,
      • Function:
      • function:Proton-linked monocarboxylate transporter. Catalyzes the rapid transport across the plasma membrane of many monocarboxylates.,similarity:Belongs to the major facilitator superfamily. Monocarboxylate porter (TC 2.A.1.13) family.,
      • Subcellular Location:
      • Cell membrane ; Multi-pass membrane protein .
      • Expression:
      • Alzheimer cortex,Brain,Brain cortex,Lung,
      • Products Images
      • Western Blot analysis of HEPG2 cells using MCT14 Polyclonal Antibody diluted at 1:1000
      • Western blot analysis of lysates from HUVEC and HepG2 cells, using MOT14 Antibody. The lane on the right is blocked with the synthesized peptide.